Results 161 to 170 of about 39,201 (181)
Time-varying characteristics of remdesivir-treated patients hospitalised due to COVID-19: an electronic health record study. [PDF]
J Glob HealthHoe JK +6 more
europepmc +1 more source
Identification and characterization of a SARS-CoV-2 M<sup>pro</sup> G23 deletion ensitrelvir-resistant mutant. [PDF]
mBioMa Y +13 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hospital Pharmacy, 2021
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Terri L. Levien, Danial E. Baker
openaire +2 more sources
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Terri L. Levien, Danial E. Baker
openaire +2 more sources
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
Clinical Microbiology and Infection, 2021François Montastruc +2 more
exaly
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
European Journal of Medicinal Chemistry, 2020Chengyuan Liang, Lei Tian, Xu Zhao
exaly
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2020Anoop Misra +2 more
exaly